At a glance
ClinicalIndex Comparison RecordN/ACompleted
Drug / intervention
iodinated contrast dye +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Role of Radiology in the Pretreatment Evaluation of Invasive Cervical Cancer
American College of Radiology Imaging Network·interventional·Posted Jan 27, 2003·Updated Jan 28, 2013
In Brief
A clinical study evaluating iodinated contrast dye, computed tomography, and 2 other interventions for Cervical Cancer. Completed, across 2 sites.
Detailed Summary
RATIONALE: Imaging procedures such as MRI or CT scans may improve the ability to detect cervical cancer and determine the extent of disease. PURPOSE: Diagnostic trial to determine the effectiveness of MRI and CT scans in evaluating invasive cervical cancer before treatment of patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCervical Cancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
N/ACompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2000
Primary CompletionMay 2001
Study CompletionOct 2002
First PostedJan 2003
TodayJul 2026
First PostedJan 27, 2003
Enrollment StartApr 1, 2000
Primary CompletionMay 1, 2001
Study CompletionOct 1, 2002
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 23.4 years ago
Interventions
iodinated contrast dyedrug
computed tomographyprocedure
magnetic resonance imagingprocedure
gadopentetate dimeglumineradiation